Methods to generate polymer scaffolds having a gradient of crosslinking density

Patent metadata

Field	Value
Publication number	US-2025263647-A1
Application number	US-202519069812-A
Country	US
Kind code	A1
Filing date	Mar 4, 2025
Priority date	Jul 27, 2016
Publication date	Aug 21, 2025
Grant date	—

Abstract

The present invention is directed to a method of making a live cell construct or a support, comprising: (a) providing a non-cellular organic polymer support having a top surface, a bottom surface, and an intermediate portion there between, and (b) contacting a cross-linking agent to one surface of said support for a time sufficient to generate a gradient of cross-linking of said polymer in said intermediate portion. Also provided are live cell constructs, supports, and methods of use of the supports and live cell constructs.

First claim

1 - 15 . (canceled)

16 . A method of making a live cell construct, comprising:
(a) providing a neutralized collagen hydrogel support comprising:
i) a first surface;
ii) a second surface; and
iii) an intermediate surface between the first surface and second surface and comprising a gradient of cross-linked neutralized collagen hydrogel, wherein the gradient of cross-linked neutralized collagen hydrogel has a higher density near the second surface than near the first surface;
(b) contacting live undifferentiated epithelial cells to the first surface of the cross-linked neutralized collagen hydrogel support, and (c) propagating a self-renewing monolayer of live primary epithelial cells comprising undifferentiated and/or differentiated live primary epithelial cells on said first surface of the cross-linked neutralized collagen hydrogel support, wherein the self-renewing monolayer is maintained or increased for at least 1 day.

17 . The method of claim 16 , wherein the gradient of cross-linked neutralized collagen comprises a stiffness between about 100 Pa to about 1,000 Pa.

18 . The method of claim 16 , wherein the live undifferentiated epithelial cells are selected from the group consisting of mammalian, avian, reptilian, amphibian, and insect cells.

19 . The method of claim 16 , wherein the live undifferentiated epithelial cells are gastrointestinal epithelial cells, urinary epithelial cells, respiratory epithelial cells, reproductive epithelial cells, endocrine and endocrine gland epithelial cells, lymph vessel epithelial cells, blood vessel epithelial cells, or ventricular ependyma epithelial cells.

20 . The method of claim 16 , wherein the live undifferentiated epithelial cells are human cells.

21 . The method of claim 16 , wherein the live undifferentiated epithelial cells are not cancer or tumor cells.

22 . The method of claim 16 , wherein the live undifferentiated epithelial cells are from the colon, small intestine, stomach, esophagus, tongue, nasopharynx, oropharynx, laryngeopharynx, pancreas, kidney, bladder, trachea, lungs, testes, ovaries, ducts of the reproductive tract, endometrium, thyroid gland, adrenal gland, parathyroid gland, ventricular ependyma, brain or combinations thereof.

23 . The method of claim 16 , further comprising:
contacting a culture media to said self-renewing monolayer of live primary epithelial cells, which culture media sustains said monolayer of live cells.

24 . The method of claim 23 , wherein said culture media comprises a short-chain fatty acid.

25 . The method of claim 24 , wherein
(i) said culture media contains not more than 10 milliMolar of monosaccharides plus disaccharides; and (ii) said culture media contains at least 2, 20, 50, or 100 milliMolar of said short chain fatty acids.

26 . The method of claim 16 , wherein said support is a porous support.

27 . The method of claim 16 , wherein said support second surface is on a porous carrier, a mesh, an inorganic grid, a hydrogel, or a combination thereof.

28 . The method of claim 16 , said first surface having a plurality of wells formed therein; each of said wells having a top opening, side walls and a floor; said epithelial cell monolayer extending onto said well side walls and floors, with the well top openings remaining open, to form open lumens lined with cells in said wells.

29 . A live cell construct, comprising:
(a) a neutralized collagen hydrogel support comprising:
i) a first surface;
ii) a second surface; and
ii) an intermediate surface between the first surface and second surface and comprising a gradient of cross-linked neutralized collagen hydrogel, wherein the gradient of cross-linked neutralized collagen hydrogel has a higher density near the second surface than near the first surface; and
(b) a self-renewing monolayer of live primary epithelial cells comprising undifferentiated and/or differentiated live primary epithelial cells formed on the first surface of the cross-linked neutralized collagen hydrogel support, wherein the self-renewing monolayer is maintained or increased for at least 1 day.

30 . The construct of claim 29 , wherein the gradient of cross-linked neutralized collagen comprises a stiffness between about 100 Pa to about 1,000 Pa.

31 . The construct of claim 29 , wherein the epithelial cells are selected from the group consisting of mammalian, avian, reptilian, amphibian, and insect cells.

32 . The construct of claim 29 , wherein the epithelial cells are gastrointestinal epithelial cells, urinary epithelial cells, respiratory epithelial cells, reproductive epithelial cells, endocrine and endocrine gland epithelial cells, lymph vessel epithelial cells, blood vessel epithelial cells, or ventricular ependyma epithelial cells.

33 . The construct of claim 29 , wherein the live undifferentiated epithelial cells are human cells.

34 . The construct of claim 29 , wherein the epithelial cells are not malignant cells.

35 . The construct of claim 29 , wherein the epithelial cells are from the colon, small intestine, stomach, esophagus, tongue, nasopharynx, oropharynx, laryngeopharynx, pancreas, kidney, ladder, trachea, lungs, testes, ovaries, ducts of the reproductive tract, endometrium, thyroid gland, adrenal gland, parathyroid gland, ventricular ependyma, brain or combinations thereof.

36 . The construct of claim 29 , further comprising:
a culture medium contacting said self-renewing monolayer of live primary epithelial cells, which culture medium sustains said monolayer of live cells.

37 . The construct of claim 36 , wherein said culture medium comprises a short-chain fatty acid.

38 . The construct of claim 29 , wherein said support is porous.

39 . The construct of claim 29 , said first surface having a plurality of wells formed therein, each of said wells having a top opening, side walls and a floor;
said epithelial cell monolayer extending onto said well side walls and floors, with said well top openings remaining uncovered, to form open cell lumens in said wells.

Assignees

• Univ North Carolina Chapel Hill

Inventors

• Allbritton Nancy
• Wang Yuli
• Gunasekara Hennayaka Mudiyanselage Dulan
• Sims Christopher

Classifications

• G01N33/5014

  for testing toxicity · CPC title

• C12N2537/10

  Cross-linking · CPC title

• C12N2533/54

  Collagen; Gelatin · CPC title

• C12N2513/00

  3D culture · CPC title

• C12N5/0679

  Cells of the gastro-intestinal tract · CPC title